Clinical Trials

Participating in Clinical Trials:

What Every Patient Needs to Know

A clinical trial is one of the final stages of a long and careful cancer fighting process. Studies are done with cancer patients to find out whether promising treatments are safe and effective.

What are Clinical Trials?

Clinical trials, also called cancer treatment or research studies, test new treatments in people with cancer. The goal of the research is to find better ways to treat cancer and help cancer patients. Clinical trials test many types of treatment such as new drugs, new approaches to surgery or radiation therapy, new combinations of treatments, or new methods such as gene therapy. A clinical trial is one of the final stages of a long and careful cancer process.

The search for new treatments begins in the laboratory, where scientists first develop and test new ideas. If an approach seems promising, the next step may be testing a treatment in animals to see how it affects cancer in a living being and whether it has harmful effects. Of course, treatments that work well in the lab or in animals do not always work well in people. Studies are done with cancer patients to find out whether promising treatments are safe and effective.

Why Are Clinical Trials Important?

Cancer affects us all, whether we have it, care about someone who does, or worry about getting it in the future. Clinical trials contribute to knowledge and progress against cancer. If a new treatment proves effective in a study, it may become a new standard treatment that can help many patients. Many of today’s most effective standard treatments are based on previous study results. Examples include treatments for breast, colon, rectal, and childhood cancers. Clinical trials may also answer important scientific questions and suggest future research directions. Because of progress made through clinical trials, many people treated for cancer are now living longer.

The patients who take part may be helped personally by the treatments they receive because they are getting the latest, most up-to-date or the best available standard treatment from cancer care experts. Of course, there is no guarantee that a new treatment being tested or a standard treatment will produce good results. New treatments may also have unknown risks. But if a new treatment proves effective or more effective than a standard treatment, clinical trial participants who receive it are among the first to benefit. Some patients receive only standard treatment and benefit from it.

In the past, clinical trials were sometimes seen as a last resort for people who had no other treatment choices. Today, patients with common cancers often choose to receive their first treatment in a clinical trial.

What Happens In A Clinical Trial?

In a clinical trial, patients receive treatment and doctors carry out research on how the treatment affects the patients. While clinical trials have risks for the people participate, each study also takes steps to protect patients.

When you take part in a clinical trial, you receive your treatment in a cancer center, hospital, clinic, and/or doctor’s office. Doctors, nurses, social workers, and other health professionals may be a part of your treatment team. They will follow your progress closely. You may have more tests and doctor visits than you would if you were not taking part in a study. You will follow a treatment plan your doctor prescribes, and you may also have other responsibilities such as keeping a log or filling out forms about your health. Some studies continue to check on patients even after their treatment is over.

How Is The Research Carried Out? How Are Patients Protected?

In clinical trials, both research concerns and patient well-being are important. To help protect patients and produce sound results, research with people is carried out according to strict scientific and ethical principles. These include:

The study’s investigator, usually a doctor, prepares an action plan for the study. Known as a protocol, this plan explains what will be done in the study and why. It outlines how many people will take part in the study, what medical tests they will receive and how often, and the treatment plan. The same protocol is used by each doctor that takes part in the study.

For patient safety, each protocol must be approved by the organization that sponsors the study (such as the National Cancer Institute) and the Institutional Review Board (IRB) at each hospital or other study site. This board, which includes consumers, clergy and health professionals, reviews the protocol to try to be sure that research will not expose patients to extreme or unethical risks.

Each study’s protocol describes the characteristics that all patients in the study must have.

Called eligibility criteria, these guidelines differ from study to study, depending on the research purpose. They may include age, gender, the type and stage of cancer, and whether cancer patients who have had prior cancer treatment or who have other health problems can take part.

Using eligibility criteria is an important principle of medical research that helps produce reliable results. During a study, they help protect patient safety, so that people who are likely to be harmed by study drugs or other treatments are not exposed to the risk. After results are in, they also help doctors know which patient groups will benefit if the new treatment being studied is proven to work. For instance, a new treatment may work for one type of cancer but not for another, or it may be more effective for men than women.

Each phase answers a different question about the new treatment.

Phase I trials are the first step in testing a new treatment in humans. In these studies, researches look for the best way to give a new treatment (e.g., by mouth, IV, drip, or injection? How many times a day?). They also try to find out if and how the treatment can be given safely (e.g. best dose?); and they watch for any harmful side effects. Because less is known about the possible risks and benefits in Phase I, these studies usually include only a limited number of patients who would not be helped by other known treatments.

Phase II trials focus on learning whether the new treatment has an anticancer effect (e.g. does it shrink a tumor? improve blood test results?). As in Phase I, only a small number of people take part because of the risks and unknowns involved.

Phase III trials compare the results of people taking the new treatment with the results of people taking standard treatment (e.g. which group has better survival rates? fewer side effects?). In most cases, studies move into Phase III testing only after a treatment shows promise in Phase I and Phase II. Phase III trials may include hundreds or thousands of people around the country.

Researchers assign patients by chance either to a group taking the new treatment (called the treatment group) or to a group taking standard treatment (called the control group). This method, called randomization, helps avoid bias: having the study’s results affected by human choices or other factors not related to the treatments being tested.

In some studies, researchers do not tell the patient whether he or she is in the treatment or control group (called a single blind study). This approach is another way to avoid bias, because when people know what drug they are taking, it might change the way they react. For instance, patients who knew they were taking the new treatment might expect it to work better and report hopeful signs because they want to believe they are getting well. This could bias the study by making results look better than they really were.

Why do Phase III clinical trials compare treatment groups?

Comparing similar groups of people taking different treatments for the same type of cancer is another way to make sure that study results are real and caused by the treatment rather than by chance or other factors. Comparing treatments with each other often shows clearly which one is more effective or has fewer side effects. Another reason Phase III trials compare the new treatment with standard treatment is so that no one in a study is left without any treatment when standard treatments is available, which would be unethical.

When no standard treatment exists for a cancer, some studies compare a new treatment with a placebo ( a look-alike pill that contains no active drug). However, you will be told if this a possibility before you decide to take part in a study.

Your Doctor Can Tell You More

If you have any questions about how clinical trials work, ask your doctor, nurse or other health professional.

Should I Take Part In A Clinical Trial?

This is a question only you, those close to you, and your health professionals can answer together. Learning you have cancer and deciding what to do about it is often overwhelming. This section has information you can use in thinking about your choices and making your decision.

Clinical Trials: Weighing the Pros and Cons

While a clinical trial is a good choice for some people, this treatment option has possible benefits and drawbacks. Here are some factors to consider. You may want to discuss them with your doctor and the people close to you.

Possible Benefits

  • Clinical Trials offer high-quality cancer care. If you are in a study and do not receive the new treatment being tested, you will receive the best standard treatment. This may be as good as or better than the new approach.
  • If a treatment approach is proven to work and you are taking it, you may be among the first to benefit.
  • By looking at the pros and cons of clinical trials and your other treatment choices, you are taking an active roles in a decision that affects your life.
  • You have the chance to help others and improve cancer treatment.

Possible Drawbacks

  • New treatments under study are not always better than, or even as good as standard care. They may have side effects that the doctors do not expect or that are worse than those of standard treatment.
  • Even if a new treatment has benefits, it may not work for you. Even standard treatments, proven effective for many people, do not help everyone.
  • Heath insurance and managed care providers do not always cover the patient care costs in a study. What they cover varies by plan and by study. To find out in advance what costs are likely to be paid in your case, talk to a doctor, nurse, or social worker from the study.

Your Rights, Your Protections

Before and during a cancer treatment study, you have a number of rights.

Knowing these can help protect you from harm.

  • Taking part in a treatment study is up to you. It may be only one of your treatment cycles. Talk with your doctor. Together, you can make the best choice for you.
  • If you do enter a study, doctors and nurses will follow your response to treatment carefully throughout the research.
  • If researchers learn that a treatment harms you, you will be taken off the study right away. You may then receive other treatment from your own doctor.

You have the right to leave a study at any time.

One of your key rights is the right to informed consent. Informed consent means that you must be given all the facts about a study before you decide whether to take part. This includes details about the treatments and tests you may receive and the possible benefits and risks they may have. The doctor or nurse will give you an informed consent form that goes over key facts. If you agree to take part in the study, you will be asked to sign this informed consent form.

The informed consent process continues throughout the study. For instance, you will be told of any new findings regarding your clinical trial, such as new risks. You may be asked to sign a new consent form if you want to stay in the study.

Signing a consent form does not mean you must stay in the study. In fact, you can leave at any time. If you choose to leave the study, you will have the chance to discuss other treatments and care with your own doctor or a doctor from the study.

You Should Ask Questions

Finding answers and making choices may be hard for people with cancer and those who care about them. It is important to discuss your treatment choices with your doctor, a cancer specialist (an oncologist) to whom your doctor may refer you, and the staff of any clinical trial you may consider entering.

Ask questions about the information you receive during the informed consent process and about any other issues that concern you. Getting answers can help you work better with the doctor. You may want to take a friend or relative along when you talk to the doctor. It may also help to write down your questions and the answers you receive, or bring a tape recorder to record what is said. No question about your care is foolish. It is very important to understand your choices.

Information courteously provided by the National Institutes of Health, National Cancer Institute.

Home | About Cancer | Our Centers | Support Groups | Clinical Trials